Alex Den­ner's firm takes over Amarin, ousts non-Saris­sa board mem­bers

Ac­tivist in­vestor Alex Den­ner has now so­lid­i­fied his con­trol over Irish drug­mak­er Amarin.

In the wake of last week’s share­hold­er elec­tion that saw Den­ner’s VC Saris­sa Cap­i­tal Man­age­ment in­stall sev­en di­rec­tors on Amarin’s board, the com­pa­ny an­nounced Mon­day af­ter­noon that the sev­en non-Saris­sa board mem­bers are ex­it­ing from their po­si­tions “to avoid fur­ther proxy con­tests.”

Mur­ray Stew­art, a for­mer CMO at GSK who was added to Amarin’s board just ear­li­er this year and was a cat­a­lyst that led to the vote, is al­so leav­ing the board.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER